Difficulty: Medium
Average Score: 88%
Practice
Giving a single IV injection of phenylephrine can be used to normalize a rapid heart rate in paroxysmal supraventricular tachycardia (PSVT). How does phenylephrine do this?
Correct answer
C
Rationale
In the context of administering phenylephrine to normalize a rapid heart rate in paroxysmal supraventricular tachycardia (PSVT), the correct answer is C) It raises blood pressure, slowing the heart via the baroreceptor reflex. Phenylephrine is a sympathomimetic agent that acts predominantly on alpha-adrenergic receptors, causing vasoconstriction and subsequently raising blood pressure.
By increasing blood pressure, phenylephrine activates the baroreceptor reflex, which leads to a vagal response resulting in a decrease in heart rate. This mechanism helps to counteract the rapid heart rate seen in PSVT.
Option A (It blocks the beta-receptors on the heart) is incorrect because phenylephrine primarily acts on alpha receptors, not beta receptors. Option B (It stimulates norepinephrine release from sympathetic nerves to the heart) is incorrect as phenylephrine itself is a sympathomimetic agent and does not stimulate norepinephrine release. Option D (It stimulates ACh esterase at parasympathetic nerves to the heart) is also incorrect because phenylephrine does not directly affect parasympathetic nerves.
Understanding the pharmacological actions of drugs used in cardiovascular conditions is crucial for healthcare professionals to make informed decisions regarding patient care. By grasping how phenylephrine functions in the context of PSVT, healthcare providers can effectively manage patients with this condition and optimize treatment outcomes.
By increasing blood pressure, phenylephrine activates the baroreceptor reflex, which leads to a vagal response resulting in a decrease in heart rate. This mechanism helps to counteract the rapid heart rate seen in PSVT.
Option A (It blocks the beta-receptors on the heart) is incorrect because phenylephrine primarily acts on alpha receptors, not beta receptors. Option B (It stimulates norepinephrine release from sympathetic nerves to the heart) is incorrect as phenylephrine itself is a sympathomimetic agent and does not stimulate norepinephrine release. Option D (It stimulates ACh esterase at parasympathetic nerves to the heart) is also incorrect because phenylephrine does not directly affect parasympathetic nerves.
Understanding the pharmacological actions of drugs used in cardiovascular conditions is crucial for healthcare professionals to make informed decisions regarding patient care. By grasping how phenylephrine functions in the context of PSVT, healthcare providers can effectively manage patients with this condition and optimize treatment outcomes.